Frontiers
US$ 28.78
sglt2 inhibitors vs glp 1 Cardiorenal Protection: Potential of and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes | Diabetes Therapy Combining GLP-1 Receptor Agonists and
Description
Proper public and patient education on the holistic management of obesity, complemented with the appropriate use of AOM, is needed to counteract the unscientific media sources
GLP-1
The focus of the Indian pharmaceutical market is increasingly shifting to biologics, including peptides, biosimilars, and GLP-1-based therapies
Heart palpitations can occur during GLP-1 therapy, but understanding the mechanisms and proper monitoring helps minimize risk
Aetna may cover Wegovy with prior authorization if you meet BMI and other criteria
